ENZY
Enzymotec Ltd
ENZY
ENZY
Delisted
ENZY was delisted on the 10th of January, 2018.
34 hedge funds and large institutions have $67.3M invested in Enzymotec Ltd in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+4
Holders Change %
+13.33%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
14
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GS
Gagnon Securities
New York
|
$2.02M |
| 2 |
Goldman Sachs
New York
|
$9.47M |
| 3 |
GA
Gagnon Advisors
New York
|
$1.59M |
| 4 |
LCM
Laurion Capital Management
New York
|
$1.57M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
$2.08M |
Top Sellers
| 1 |
VAM
Visium Asset Management
New York
|
$0 |
| 2 |
TM
Tiger Management
New York
|
$4.83M |
| 3 |
Morgan Stanley
New York
|
$102K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
$185K |
| 5 |
Millennium Management
New York
|
$682K |
